DexCom Aktie
82,11
EUR
+3,59
EUR
+4,57
%
84,36
USD
-0,44
USD
-0,52
%
Werbung
DexCom Aktie Analyse
02.08.18 | DexCom Buy | Canaccord Adams | |
03.05.18 | DexCom Buy | Canaccord Adams | |
23.03.18 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
28.09.17 | DexCom Outperform | Wedbush Morgan Securities Inc. | |
15.09.17 | DexCom Equal weight | Barclays Capital | |
03.05.17 | DexCom Buy | Canaccord Adams | |
02.11.16 | DexCom Buy | Canaccord Adams | |
24.02.16 | DexCom Buy | The Benchmark Company | |
Werbung
|
|||
06.08.15 | DexCom Buy | Canaccord Adams | |
08.07.15 | DexCom Outperform | Robert W. Baird & Co. Incorporated | |
30.04.15 | DexCom Perform | Oppenheimer & Co. Inc. | |
27.01.15 | DexCom Perform | Oppenheimer & Co. Inc. | |
24.10.06 | DexCom Outperform | Piper Jaffray |
Werbung